Global and United States Cell-Free DNA (cfDNA) Testing Market Report & Forecast 2022-2028
SKU ID : QYR-20641405 | Publishing Date : 01-Apr-2022 | No. of pages : 103
Detailed TOC of Global and United States Cell-Free DNA (cfDNA) Testing Market Report & Forecast 2022-2028
1 Study Coverage1.1 Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Introduction
1.2 Global Cell-Free DNA (cfDNA) Testing Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size for the Year 2017-2028
1.2.2 Global Cell-Free DNA (cfDNA) Testing Market Size for the Year 2017-2028
1.3 Cell-Free DNA (cfDNA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Cell-Free DNA (cfDNA) Testing in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Cell-Free DNA (cfDNA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Cell-Free DNA (cfDNA) Testing Market Dynamics
1.4.1 Cell-Free DNA (cfDNA) Testing Industry Trends
1.4.2 Cell-Free DNA (cfDNA) Testing Market Drivers
1.4.3 Cell-Free DNA (cfDNA) Testing Market Challenges
1.4.4 Cell-Free DNA (cfDNA) Testing Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Cell-Free DNA (cfDNA) Testing by Type
2.1 Cell-Free DNA (cfDNA) Testing Market Segment by Type
2.1.1 Donor-Derived Cell-Free DNA (DdcfDNA)
2.1.2 Circulating Cell-Free Tumor DNA (CtDNA)
2.1.3 Cell-Free Fetal DNA (NIPT)
2.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017, 2022 & 2028)
2.3 Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028)
2.4 United States Cell-Free DNA (cfDNA) Testing Market Size by Type (2017, 2022 & 2028)
2.5 United States Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028)
3 Cell-Free DNA (cfDNA) Testing by Application
3.1 Cell-Free DNA (cfDNA) Testing Market Segment by Application
3.1.1 Hospital
3.1.2 Ambulatory Surgical Centers
3.1.3 Cancer Research Institutes
3.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017, 2022 & 2028)
3.3 Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028)
3.4 United States Cell-Free DNA (cfDNA) Testing Market Size by Application (2017, 2022 & 2028)
3.5 United States Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028)
4 Global Cell-Free DNA (cfDNA) Testing Competitor Landscape by Company
4.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Company
4.1.1 Top Global Cell-Free DNA (cfDNA) Testing Companies Ranked by Revenue (2021)
4.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue by Player (2017-2022)
4.2 Global Cell-Free DNA (cfDNA) Testing Concentration Ratio (CR)
4.2.1 Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cell-Free DNA (cfDNA) Testing in 2021
4.2.3 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cell-Free DNA (cfDNA) Testing Headquarters, Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Type
4.3.1 Global Cell-Free DNA (cfDNA) Testing Headquarters and Area Served
4.3.2 Global Cell-Free DNA (cfDNA) Testing Companies Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Cell-Free DNA (cfDNA) Testing Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Cell-Free DNA (cfDNA) Testing Market Size by Company
4.5.1 Top Cell-Free DNA (cfDNA) Testing Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cell-Free DNA (cfDNA) Testing Revenue by Players (2020, 2021 & 2022)
5 Global Cell-Free DNA (cfDNA) Testing Market Size by Region
5.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2028)
5.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2017-2022
5.2.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028
6.1.2 North America Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028
6.3.2 Europe Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028
6.4.2 Latin America Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Agilent Technology
7.1.1 Agilent Technology Company Details
7.1.2 Agilent Technology Business Overview
7.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
7.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.1.5 Agilent Technology Recent Development
7.2 Allenex
7.2.1 Allenex Company Details
7.2.2 Allenex Business Overview
7.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
7.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.2.5 Allenex Recent Development
7.3 Biocept
7.3.1 Biocept Company Details
7.3.2 Biocept Business Overview
7.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
7.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.3.5 Biocept Recent Development
7.4 Biodesix
7.4.1 Biodesix Company Details
7.4.2 Biodesix Business Overview
7.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
7.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.4.5 Biodesix Recent Development
7.5 CareDx
7.5.1 CareDx Company Details
7.5.2 CareDx Business Overview
7.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
7.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.5.5 CareDx Recent Development
7.6 Guardant Health
7.6.1 Guardant Health Company Details
7.6.2 Guardant Health Business Overview
7.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
7.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.6.5 Guardant Health Recent Development
7.7 Illumania
7.7.1 Illumania Company Details
7.7.2 Illumania Business Overview
7.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
7.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.7.5 Illumania Recent Development
7.8 Invited
7.8.1 Invited Company Details
7.8.2 Invited Business Overview
7.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
7.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.8.5 Invited Recent Development
7.9 Natera
7.9.1 Natera Company Details
7.9.2 Natera Business Overview
7.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
7.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.9.5 Natera Recent Development
7.10 Quest Diagnostics
7.10.1 Quest Diagnostics Company Details
7.10.2 Quest Diagnostics Business Overview
7.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
7.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.10.5 Quest Diagnostics Recent Development
7.11 Roche Holdings
7.11.1 Roche Holdings Company Details
7.11.2 Roche Holdings Business Overview
7.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
7.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.11.5 Roche Holdings Recent Development
7.12 Sequenom
7.12.1 Sequenom Company Details
7.12.2 Sequenom Business Overview
7.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
7.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.12.5 Sequenom Recent Development
7.13 Trovagene
7.13.1 Trovagene Company Details
7.13.2 Trovagene Business Overview
7.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
7.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
7.13.5 Trovagene Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Cell-Free DNA (cfDNA) Testing Market Report & Forecast 2022-2028
List of TablesTable 1. Cell-Free DNA (cfDNA) Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Cell-Free DNA (cfDNA) Testing Market Trends
Table 3. Cell-Free DNA (cfDNA) Testing Market Drivers
Table 4. Cell-Free DNA (cfDNA) Testing Market Challenges
Table 5. Cell-Free DNA (cfDNA) Testing Market Restraints
Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Cell-Free DNA (cfDNA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Cell-Free DNA (cfDNA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Cell-Free DNA (cfDNA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Cell-Free DNA (cfDNA) Testing Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Cell-Free DNA (cfDNA) Testing Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Player, 2017-2022
Table 13. Global Cell-Free DNA (cfDNA) Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cell-Free DNA (cfDNA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2021)
Table 15. Top Players of Cell-Free DNA (cfDNA) Testing in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Cell-Free DNA (cfDNA) Testing Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Cell-Free DNA (cfDNA) Testing Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Cell-Free DNA (cfDNA) Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Cell-Free DNA (cfDNA) Testing Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Agilent Technology Company Details
Table 31. Agilent Technology Business Overview
Table 32. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
Table 33. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 34. Agilent Technology Recent Development
Table 35. Allenex Company Details
Table 36. Allenex Business Overview
Table 37. Allenex Cell-Free DNA (cfDNA) Testing Product
Table 38. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 39. Allenex Recent Development
Table 40. Biocept Company Details
Table 41. Biocept Business Overview
Table 42. Biocept Cell-Free DNA (cfDNA) Testing Product
Table 43. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 44. Biocept Recent Development
Table 45. Biodesix Company Details
Table 46. Biodesix Business Overview
Table 47. Biodesix Cell-Free DNA (cfDNA) Testing Product
Table 48. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 49. Biodesix Recent Development
Table 50. CareDx Company Details
Table 51. CareDx Business Overview
Table 52. CareDx Cell-Free DNA (cfDNA) Testing Product
Table 53. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 54. CareDx Recent Development
Table 55. Guardant Health Company Details
Table 56. Guardant Health Business Overview
Table 57. Guardant Health Cell-Free DNA (cfDNA) Testing Product
Table 58. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 59. Guardant Health Recent Development
Table 60. Illumania Company Details
Table 61. Illumania Business Overview
Table 62. Illumania Cell-Free DNA (cfDNA) Testing Product
Table 63. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 64. Illumania Recent Development
Table 65. Invited Company Details
Table 66. Invited Business Overview
Table 67. Invited Cell-Free DNA (cfDNA) Testing Product
Table 68. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 69. Invited Recent Development
Table 70. Natera Company Details
Table 71. Natera Business Overview
Table 72. Natera Cell-Free DNA (cfDNA) Testing Product
Table 73. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 74. Natera Recent Development
Table 75. Quest Diagnostics Company Details
Table 76. Quest Diagnostics Business Overview
Table 77. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
Table 78. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 79. Quest Diagnostics Recent Development
Table 80. Roche Holdings Company Details
Table 81. Roche Holdings Business Overview
Table 82. Roche Holdings Cell-Free DNA (cfDNA) Testing Product
Table 83. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 84. Roche Holdings Recent Development
Table 85. Sequenom Company Details
Table 86. Sequenom Business Overview
Table 87. Sequenom Cell-Free DNA (cfDNA) Testing Product
Table 88. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 89. Sequenom Recent Development
Table 90. Trovagene Company Details
Table 91. Trovagene Business Overview
Table 92. Trovagene Cell-Free DNA (cfDNA) Testing Product
Table 93. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
Table 94. Trovagene Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell-Free DNA (cfDNA) Testing Product Picture
Figure 2. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Cell-Free DNA (cfDNA) Testing Market Size 2017-2028 (US$ Million)
Figure 4. United States Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Cell-Free DNA (cfDNA) Testing Market Size 2017-2028 (US$ Million)
Figure 6. United States Cell-Free DNA (cfDNA) Testing Market Share in Global 2017-2028
Figure 7. Cell-Free DNA (cfDNA) Testing Report Years Considered
Figure 8. Product Picture of Donor-Derived Cell-Free DNA (DdcfDNA)
Figure 9. Product Picture of Circulating Cell-Free Tumor DNA (CtDNA)
Figure 10. Product Picture of Cell-Free Fetal DNA (NIPT)
Figure 11. Global Cell-Free DNA (cfDNA) Testing Market Share by Type in 2022 & 2028
Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028)
Figure 14. United States Cell-Free DNA (cfDNA) Testing Market Share by Type in 2022 & 2028
Figure 15. United States Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospital
Figure 18. Product Picture of Ambulatory Surgical Centers
Figure 19. Product Picture of Cancer Research Institutes
Figure 20. Global Cell-Free DNA (cfDNA) Testing Market Share by Application in 2022 & 2028
Figure 21. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028)
Figure 23. United States Cell-Free DNA (cfDNA) Testing Market Share by Application in 2022 & 2028
Figure 24. United States Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028)
Figure 26. North America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.A.E Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 55. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 56. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 57. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 58. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 59. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 60. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 61. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 62. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 63. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 64. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 65. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 66. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global and United States Cell-Free DNA (cfDNA) Testing Market Report & Forecast 2022-2028
Agilent TechnologyAllenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene